Metabolic-rejuvenation and longevity research central to an emerging research framework that connects methylation tone, NAD availability and tissue-specific aging [1,3]
[23] In two clinical trials, hypothyroid patients who took selenium showed reduced thyroid antibodies compared to a placebo [24] and improved ultrasound findings
The field is evolving quickly, with new, more effective options and research emerging constantly
A recent meta-analysis of mixed evidence (5 RCTs 52,183,184,185,186 and 1 cohort study 187 ) in 2,071 people with T2DM or Parkinsons disease suggested antidepressant efficacy of the GLP-1RAs exenatide and liraglutide over 2452 weeks 188
The reduction in long-COVID risk observed in both younger and older populations suggest a broad applicability across different age groups, which is critical given the heterogeneity in long-COVID presentation